Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

GSK to buy phase III-ready drug efimosfermin

The Boston Globe · 6h
GSK buys liver drug from Boston Pharmaceuticals for up to $2 billion
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the promising field of liver therapies.
Seeking Alpha on MSN · 22h
GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B
British pharmaceutical company GSK (NYSE:GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 billion in cash. Under the agreement, GSK will pay $1.2 billion upfront,
STAT · 15h
GSK to buy experimental MASH drug for $1.2B upfront
GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.
23h
GSK to buy efimosfermin for up to $2 billion
GSK will buy efimosfermin, a specialty medicine used to treat liver disease from Boston Pharmaceuticals, for up to $2 billion ...
Medscape
5d
Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial
Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now

Judge orders release
Harvard scientist charged
Public health alert issued
Agrees to pay nearly $330K
On ending free health care
Undergoes heart surgery
Oscar-winning director dies
Fires top NIC officials
NYC loses jail control
Bailey gets restraining order
Delivery driver pleads guilty
Qatar signs Boeing deal
To recall 273K+ vehicles
2-yr-old reunites w/ mother
To weaken PFAS limits
Virginia boy found dead
SC abortion ban ruling
New Air Force secretary
Visible auroras on Mars
Under Medicare fraud probe?
Wildfires in Northern MN
Chemical plant blast in Spain
Announces retirement
Ex-US Guardsman arrested
Las Vegas man sentenced
Tatum undergoes surgery
US overdose deaths fell
Meets new Syrian leader
Former MO governor dies
Placed on injured list
Green fined $50K by NBA
Lord Buffalo cancels tour

Related topics

GSK
GlaxoSmithKline
Efimosfermin
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy